Fibrinous pneumonia

Fibrinous pneumonia is an acute inflammation of the lungs caused by streptococcus pneumoniae. It is characterized by the development of fibrinous exudates in the alveoli and bronchioles, leading to severe respiratory failure.

Causes

The causative agent of fibrinous pneumonia is Streptococcus pneumoniae (pneumococcus). Pneumococci are gram-positive diplococci containing a polysaccharide capsule. There are more than 90 serotypes of pneumococcus, differing in the structure of the capsule.

Ways of transmission of infection:

1. Airborne (from coughing, sneezing)

2. Contact

3. Aspiration

At-risk groups:

1. Children

2. Aged people

3. Persons with reduced immunity

4. Persons with chronic lung diseases

Symptoms

1. High temperature (up to 39-40 degrees)

2. Chills, sweating

3. Cough with hard-to-clear sputum

4. Dyspnea

5. Chest pain when breathing

6. Cardiopalmus

7. Headache, weakness

Complications

1. Respiratory failure

2. Sepsis

3. Empyema of the pleura

4. Meningitis, pericarditis

Diagnostics

1. Physical examination

2. Sputum analysis

3. General blood analysis

4. X-ray of the chest organs

5. Pulse oximetry

Treatment

1. Antibiotics (amoxicillin, cephalosporins, macrolides)

2. Inhalation oxygen

3. Antipyretic drugs

4. Expectorants

5. Infusion therapy

6. In severe cases - mechanical ventilation

Prevention

1. Vaccination

2. Avoid contact with sick people

3. Healthy lifestyle

4. Strengthening the immune system

Thus, fibrinous pneumonia is a severe inflammation of the lungs caused by pneumococcus. It is characterized by severe symptoms of intoxication, damage to lung tissue and respiratory failure. Requires timely treatment with antibiotics and supportive care. Vaccination plays an important role in prevention.